Odiparcil (Standard)
Odiparcil (Standard) is the analytical standard of Odiparcil (HY-10277). This product is intended for research and analytical applications. Odiparcil (SB-424323) is an orally active β-D-xyloside derivative. Odiparcil can effectively divert the synthesis of cellular glycosaminoglycans (GAG) into secreted soluble species and reduce GAG accumulation. Odiparcil shows antithrombin and antiplatelet activity. Odiparcil can be used for the researches of metabolic and cardiovascular disease, such as mucopolysaccharidoses (MPS) and thrombosis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 137215-12-4
- 화학식: C15H16O6S
- 분자량:324.35
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- 순도&문서
-
Help & FAQs
-
HY-10277
Odiparcilβ-D-xyloside Derivative -
HY-10787
XimelagatranThrombin Inhibitor -
HY-B0375
ArgatrobanThrombin Inhibitor -
HY-10163
DabigatranThrombin Inhibitor -
HY-10274A
Dabigatran etexilate mesylateAntithrombotic Agent -
HY-B0375A
Argatroban monohydrateThrombin Inhibitor -
HY-10163R
Dabigatran (Standard)Thrombin Inhibitor -
HY-129056
MelagatranThrombin Inhibitor -
HY-10274
Dabigatran etexilateAntithrombotic Agent -
HY-B0375R
Argatroban (Standard)Thrombin Inhibitor -
HY-B0209
MetolazoneDiuretics -
HY-P1000
TRAP-14Thrombin Receptor Agonist
Product Information
Information
신청
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 137215-12-4
-
분자량 324.35
-
화학식 C15H16O6S
-
SMILES
CC(C1=CC=C(O[C@H]2[C@@H]([C@H]([C@@H](CS2)O)O)O)C=C1O3)=CC3=O
-
Synonyms
SB-424323 (Standard)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Entchev E, et al. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models. PLoS One. 2020 May 15;15(5):e0233032. [Content Brief]
[2]. Toomey JR, et al. A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. J Thromb Haemost. 2006 Sep;4(9):1989-96. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Odiparcil (Standard) Related Classifications
HY-10277R Related Classifications
Powered by Bioz